Restoring the sense of smell based on the patient's own cells
The doctors of the European Medical Center (EMC) were the first in Russia to introduce PRP therapy into their practice to restore the sense of smell after suffering from COVID-19, nasal injuries, infectious diseases and age-related changes. The method shows its effectiveness already within a month after the procedure.
PRP therapy involves injecting your own concentrated blood plasma with platelets into the nasal mucosa. The procedure itself involves taking a small amount of blood from a vein and injecting plasma. It takes no more than 30 minutes. The course includes 2-4 procedures with a break of 3-4 weeks.
EMC doctors have been successfully using various techniques based on enriched plasma for many years, and now they will use it to restore their sense of smell. According to internal data, about 60-80% of patients notice improvement after the course, and special tests confirm the restoration of the sense of smell in 40-70% of cases. The most optimal time to start PRP therapy is the first 6-12 months after the loss or decrease of the sense of smell.
"A violation or loss of the sense of smell directly correlates with a person's quality of life and psychological health, can deprive him of the joys of life — the aroma of coffee in the morning and his favorite perfumes, and also affects his identity. Unfortunately, the COVID-19 pandemic has negatively affected people's sense of smell, and classical methods do not always solve this problem. And new methods, such as PRP therapy, give patients a chance to fully regain their ability to smell in a relatively short period of time. At the moment, such a procedure is only available in EMC, since the injection of plasma into the nasal mucosa requires high qualifications and special experience of an ENT doctor who knows endoscopic and injection techniques in an anatomically complex area.b>",- Irakli Yakobashvili,Candidate of Medical Sciences, Doctor of the highest category, Head of the Department of Otorhinolaryngology of the EMC.
The effectiveness of PRP therapy was confirmed immediately in several groups of patients who had problems with their sense of smell. Thus, after viral infections, including COVID-19, 62% of patients have a significantly improved sense of smell within a month. Without treatment, this improvement is observed only in 28%. With chronic rhinitis and sinusitis, every second patient (55%) feels at least half of the improvement, and without PRP therapy, it occurs only in every fifth (20%). After injuries to the nose or head, enriched plasma helps to fully restore the sense of smell in 15% of cases and partially in 40%.
PRP therapy has been successfully used for more than 20 years in orthopedics, dermatology and dentistry for faster tissue regeneration. But using PRP to restore the sense of smell is a new direction that has been implemented so far only in isolated clinics around the world.
Doctors

- Performs the full range of outpatient care, planned and emergency surgery of ENT organs
- He defended his PhD thesis at the Scientific Research Institute of Ear, Throat, Nose and Speech in Moscow. St. Petersburg
- Confirmed the specialization of an otorhinolaryngologist in Israel (Israel Medical Association)
